Hyperuricemia and chronic kidney disease

  • Olga Kompaniets State Institution “Institute of Nephrology of the National Academy of Medical Sciences of Ukraine”
DOI: https://doi.org/10.31450/ukrjnd.2(70).2021.09
Keywords: сhronic kidney disease, hyperuricemia, uric acid, gouty nephropathy, cardiorenal syndrome, endothelial dysfunction, metabolic syndrome.

Abstract

The article is devoted to a review of the literature on the impact of hyperuricemia on the development and progression of chronic kidney disease (CKD). The tendency of changes of views on the role of uric acid in the pathogenesis of CKD is demonstrated. An analysis of experimental, epidemiological and clinical studies on the effects of uric acid on the physiology of the nephron and endothelial tissues, the relationship of hyperuricemia with metabolic and cardiorenal syndromes.

Downloads

Download data is not yet available.

References

Richard J Johnson 1, Takahiko Nakagawa, Diana Jalal, Laura Gabriela Sánchez-Lozada, Duk-Hee Kang, Eberhard Ritz. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant 2013;28:2221-28. doi: 10.1093/ndt/gft029.

Barlow KA, Beilin LJ. Renal disease in primary gout. Q J Med. 1968;37(145):79-96.

Шуба НМ. Гиперурикемия - мультиморбидная патология в ревматологии. Український ревматологічний журнал 2013;52(2):14-22.

Terkeltaub R, Bushinsky DA, Becker MA. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther. 2006;8 Suppl 1(Suppl 1):S4. doi: 10.1186/ar1909.

Rabadi MM, Kuo MC, Ghaly T, et al. Interaction between uric acid and HMGB1 translocation and release from endothelial cells. 2012;302(6):F730–F741. doi: 10.1152/ajprenal.00520.2011.

Weaver DJ Jr. Uric acid and progression of chronic kidney disease. Pediatr Nephrol. 2019;34(5):801-809. doi: 10.1007/s00467-018-3979-2.

Mazzali M, Kanellis J, Han L, Feng L, Xia Y, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood-pressure-independent mechanism Am J Physiol 2002 282:6, F991-F997. doi: 10.1152/ajprenal.00283.2001.

Pacifico L, Cantisani V, Anania C, Bonaiuto E, Martino F, Pascone R, et al. Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children. Eur J Endocrinol. 2009 Jan;160(1):45-52. doi: 10.1530/EJE-08-0618.

Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J. 1999 May 15;340 ( Pt 1)(Pt 1):143-52.

Sánchez-Lozada LG, Tapia E, Santamaría J, Avila-Casado C, Soto V, Nepomuceno T, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005;67(1):237-47. doi: 10.1111/j.1523-1755.2005.00074.x.

Johnson RJ, Perez-Pozo SE, Sautin YY, et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev. 2009;30:96–116. doi: 10.1210/er.2008-0033.

Demikhov O, Dehtyarova I, Demikhova N. Actual aspects of public health policy formation on the example of Ukraine. Bangladesh Journal of Medical Science 2020; 19(3):358-364. doi:10.3329/bjms.v19i3.45850.

Коли безсимптомна гіперурікемія потребує лікування? Український ревматологічний журнал 2020;79(1):40-46. doi: 10.32471/rheumatology.2707-6970.79.14918

Demihova N, Lidiya C, Chernatska O, Mazur T, Aleksakhina T, Demikhov O. The Relationship Between Lipid Metabolism and The Level of Albuminuria with Single Nucleotide Polymorphism -204A>C [rs 3808607] CYP7A1 Gene in Patients with Type 2 Diabetes Mellitus and Diabetic Nephropathy. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2019;26(3): 253-260. doi: 10.2478/rjdnmd-2019-0026.Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk [published correction appears in N Engl J Med. 2010;362(23):2235]. N Engl J Med. 2008;359(17):1811-1821. doi:10.1056/NEJMra0800885

Stepanova N, Snisar L, Lebid L. Hyperuricemia Predicts Residual Diuresis Decline in Peritoneal Dialysis Patients. Electron J Gen Med. 2021;18(1):em270. doi: 10.29333/ejgm/9297.

El Ridi R, Tallima H. Physiological functions and pathogenic potential of uric acid: A review. J Adv Res. 2017;8(5):487-493. doi:10.1016/j.jare.2017.03.003.

Son CN, Kim JM, Kim SH, et al. Prevalence and possible causes of hypouricemia at a tertiary care hospital. Korean J Intern Med. 2016;31(5):971-976. doi:10.3904/kjim.2015.125.

Bairaktari ET, Kakafika AI, Pritsivelis N, Hatzidimou KG, Tsianos EV, Seferiadis KI, et al. Hypouricemia in individuals admitted to an inpatient hospital-based facility. Am J Kidney Dis. 2003 Jun;41(6):1225-32. doi: 10.1016/s0272-6386(03)00355-x.

Chaudhary K, Malhotra K, Sowers J, Aroor A. Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 2013;3(3):208-220. doi: 10.1159/000355405.

Shi Y, Chen W, Jalal D, Li Z, Chen W, Mao H, et al. Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial. Kidney Blood Press Res. 2012;35(3):153-60. doi: 10.1159/000331453.

Stepanova N, Burdeyna O, Snisar L. Hyperuricemia is associated with cardiovascular events and all-cause mortality in peritoneal dialysis patients. Nephr Dial Transpl. 2019;34(1):i242. doi:10.1093/ndt/gfz106.FP587.

Stepanova N, Snisar L, Lebid L, Savchenko S, Nepomnyashchii V, Kolesnyk M. Serum uric acid and renal survival prognosis in primary glomerulonephritis patients in a retrospective single-center cohort. J Renal Inj Prev 2021;10(2): e11-e11. doi: 10.34172/jrip.2021.11.

Vasylchenko V, Korol L, Kuchmenko O, Stepanova N. The oxidative status in patients with chronic kidney disease. Ukr Biochem J 2020;92(5):70-77. doi: 10.15407/ubj92.05.070.

Sowers JR. Diabetes mellitus and vascular disease. Hypertension. 2013;61(5):943-7. doi: 10.1161/HYPERTENSIONAHA.111.00612.

Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, et al. Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant. 2010 Jun;25(6):1865-9. doi: 10.1093/ndt/gfp740.

Kolesnуk M, Stepanova N, Snisar L,  Lebid L, Nepomnyaschii V, Savchenko S. Uric acid and the risk of kidney failure in primary glomerulonephritis patients with nephrotic syndrome: preliminary results of an ongoing single-center prospective study. Ukr J Nephr Dial. 2020;1(65):29-35. doi: 10.31450/ukrjnd.1(65).2020.05.

Lipkowitz MS. Regulation of Uric Acid Excretion by the Kidney. Curr Rheumatol Rep 2012;14(2):179-88. doi: 10.1007/s11926-012-0240-z.

Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS, Jo I, Johnson RJ, Kang DH. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol. 2013 Mar 1;304(5):F471-80. doi: 10.1152/ajprenal.00560.2012.

 


Abstract views: 502
PDF Downloads: 19468
Published
2021-03-25
How to Cite
Kompaniets, O. (2021). Hyperuricemia and chronic kidney disease. Ukrainian Journal of Nephrology and Dialysis, (2(70), 77-81. https://doi.org/10.31450/ukrjnd.2(70).2021.09
Issue
No 2(70) (2021): Ukrainian Journal of Nephrology and Dialysis
Section
Nephrology School